P1.07-039 Blood Biomarkers Correlate with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti PD-1 Antibodies

A. Soyano,B. Dholaria,J. Marin,N. Diehl,D. Hodge,Y. Luo,L. Yang,A. Adjei,K. Knutson, Y. Lou

Journal of Thoracic Oncology（2017）

引用 72|浏览15

暂无评分

摘要

Anti-PD-1 antibodies have demonstrated improved overall survival (OS) and progression free survival (PFS) in a subset of patients with metastatic or locally advanced non-small cell lung cancer (NSCLC). Currently, no blood biomarkers in NSCLC predict clinical outcome to anti-PD-1 antibodies.

查看译文

关键词

blood biomarkers correlate,cell lung cancer,lung cancer,non-small

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要